These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3018955

  • 1. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis.
    Freyssinet JM, Wiesel ML, Gauchy J, Boneu B, Cazenave JP.
    Thromb Haemost; 1986 Jun 30; 55(3):309-13. PubMed ID: 3018955
    [Abstract] [Full Text] [Related]

  • 2. [Circulating lupus-type anticoagulant, a risk factor for thrombosis by inhibition of protein C activation].
    Cariou R, Tobelem G, Caen J.
    C R Acad Sci III; 1986 Jun 30; 303(4):113-8. PubMed ID: 3019490
    [Abstract] [Full Text] [Related]

  • 3. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
    Tsakiris DA, Settas L, Makris PE, Marbet GA.
    J Rheumatol; 1990 Jun 30; 17(6):785-9. PubMed ID: 2167370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protein C.
    Esmon CT.
    Prog Hemost Thromb; 1984 Jun 30; 7():25-54. PubMed ID: 6099583
    [Abstract] [Full Text] [Related]

  • 7. [Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms].
    Lobato-Mendizábal E, Ruiz-Argüelles GJ.
    Rev Invest Clin; 1990 Jun 30; 42(1):54-62. PubMed ID: 2173090
    [Abstract] [Full Text] [Related]

  • 8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 30; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N.
    Thromb Haemost; 1999 Mar 30; 81(3):436-41. PubMed ID: 10102474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep 30; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 16. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
    Ravanat C, Archipoff G, Beretz A, Freund G, Cazenave JP, Freyssinet JM.
    Biochem J; 1992 Feb 15; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
    [Abstract] [Full Text] [Related]

  • 17. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
    Carreras LO, Vermylen JG.
    Thromb Haemost; 1982 Aug 24; 48(1):38-40. PubMed ID: 6813993
    [Abstract] [Full Text] [Related]

  • 18. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep 24; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J, Ido M, Hayashi T, Suzuki K.
    Thromb Haemost; 1996 Feb 24; 75(2):275-82. PubMed ID: 8815576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.